Executive Director, Intellectual Property & Legal
Angitia Biopharmaceuticals
This listing was originally posted on Angitia Biopharmaceuticals's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moPosition: Executive Director, Intellectual Property & Legal
Department: Operations
Location: Remote with up to 20% domestic travel
Reports To: Chief Operating Officer
Position Summary
The Executive Director, Intellectual Property & Legal will be responsible for leading and elevating our global IP strategy as we advance toward commercialization. Reporting to the Chief Operating Officer, this role will serve as the company’s senior IP authority and a key member of the legal leadership team, responsible for shaping and executing a comprehensive intellectual property strategy across our research projects to late-stage clinical and future commercial programs.
This individual will combine strategic leadership with hands-on execution, partnering closely with R&D, Clinical, CMC, Business Development, and Executive Leadership to maximize portfolio value, secure competitive advantage, and mitigate risk. In addition to leading the IP function, this role will have the opportunity to oversee and develop the broader in-house legal team supporting U.S. and International operations.
This is a high-impact role within a growing, mission-driven biopharmaceutical organization preparing for commercialization.
Responsibilities
IP Strategy & Portfolio Leadership
Business Development & Transactional Support
Disputes & Risk Management
Legal Leadership & Operational Excellence
Qualifications
Preferred Qualifications
Leadership Profile
Salary Range: $270,000 - $340,000
About Angitia
Established in June 2018, Angitia Biopharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases. Angitia is currently studying 3 biologic product candidates in the clinic for the treatment of osteoporosis, osteogenesis imperfecta (OI), and spinal fusion. Leveraging the team's extensive experience and scientific acumen in novel drug development, Angitia is committed to providing groundbreaking therapies to satisfy key unmet medical needs. The founder and the core team members of Angitia are seasoned scientific leaders in new drug discovery, development, and management from both overseas and domestic large multinational companies. The company has built its headquarters in Westlake Village, CA, USA, and offices in Guangzhou, China, which is distinguished by world-class scientists with talents that are proficient in the pathophysiology of musculoskeletal diseases. The company is committed to serving patients in need by carrying out innovative science, including internal research and external collaborations with academics and global biopharmaceutical companies. We are seeking talented individuals who are innovative, ambitious, and great team players to join our vibrant group.
Learn more at www.angitiabio.com.
Benefits:
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Angitia Biopharmaceuticals?
Help others prepare — share your experience anonymously.
PHARMACEUTICAL
Bispecific Antibody
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo